Efficacy and safety of endoscopic submucosal dissection for gastric cancer in patients with liver cirrhosis

Authors:
  • MOM. Okamoto
    M. Okamoto
  • TST. Sugimoto
    T. Sugimoto
  • NYN. Yahagi
    N. Yahagi
  • MFM. Fujishiro
    M. Fujishiro
  • NKN. Kakushima
    N. Kakushima
  • SKS. Kodashima
    S. Kodashima
  • TKT. Kawabe
    T. Kawabe
  • MOM. Omata
    M. Omata

Abstract
Endoscopic submucosal dissection (ESD) has become a widely accepted method for treating gastrointestinal cancer. The aim of this study was to evaluate the efficacy and safety of ESD for gastric cancer in patients with liver cirrhosis. A total of 18 gastric cancers were treated by ESD in 15 patients with cirrhosis. The rate of en bloc resection was 88.9 % (16/18). En bloc resection with tumor-free lateral/basal margins (R0 resection) was 77.8 % (14/18). Three patients had postoperative bleeding and underwent emergency gastroscopy for hemostasis. No recurrence was observed during the median follow-up of 21.4 months, excluding three patients in whom additional endoscopic resection or surgery was carried out. ESD can be safely performed for gastric cancer in patients with cirrhosis, resulting in a high en bloc resection rate.